drugset / Trial / NCT05771831
Thrombosomes® in Acute Thoracic Aortic Dissections
RandomizedParallel-groupOpen-labelTreatment
Summary
The hypothesis is that administration of Thrombosomes® (TBX®) as hemostatic support when terminating the cardiopulmonary bypass (CPB) in patients undergoing emergency surgery for acute thoracic aortic dissection (aTAD) is safe and least as effective when compared to standard Platelet Concentrates (stPC).
Timeline
- Start
- 2023-03-15
- Primary completion
- 2024-04-11
- Completion
- 2024-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Standard platelet concentrate | Unknown | — | — |
| Subject | Thrombosomes | Other / unclassified | — | Intravenous |